General discussion and future perspectives 229 102. Yang Y, Cao M, Sheng K, Gao Y, Chen A, Kamrava M, et al. Longitudinal diffusion MRI for treatment response assessment: Preliminary experience using an MRI-guided tri-cobalt 60 radiotherapy system. Med Phys 2016;43:1369–73. 103. Park SY, Kim CK, Park BK, Park W, Park HC, Han DH, et al. Early Changes in Apparent Diffusion Coefficient From Diffusion-Weighted MR Imaging During Radiotherapy for Prostate Cancer. Int J Radiat Oncol 2012;83:749–55. 104. Supiot S, Rousseau C, Dore M, Cheze-Le-Rest C, Kandel-Aznar C, Potiron V, et al. Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using 18 F-fluoromisonidazole PET/CT: a pilot study. Oncotarget; Vol 9, No 11 2018. 105. Lam WW, Oakden W, Murray L, Klein J, Iorio C, Screaton RA, et al. Differentiation of Normal and Radioresistant Prostate Cancer Xenografts Using Magnetization Transfer-Prepared MRI. Sci Rep 2018;8:10447. 11
RkJQdWJsaXNoZXIy MTk4NDMw